Benitec Biopharma share price logo

Benitec Biopharma

NASDAQ: BNTC

Small Cap

$8.49

-0.25

(-2.86%)

as on

Benitec Biopharma Stock Performance

as on November 3, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $8.24
    $8.81
    downward going graph

    2.94%

    Downside

    3.77%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.89
    $16.31
    downward going graph

    7.13%

    Downside

    92.11%

    Upside

    downward going graph

Benitec Biopharma share price movements today

Previous Close
$8.74
Open
$8.81
Volume
377.6K
Market Cap
$304.9M
Day's Low - High
$8.24 - $8.81
52 Week Low - High
$7.89 - $16.31

Benitec Biopharma Historical Returns

1 Month Return
-2.67 %
3 Month Return
-25.36 %
1 Year Return
-46.58 %
3 Year Return
+ 142.11 %
5 Year Return
-86.33 %

Benitec Biopharma Stock Fundamentals & Key Indicators

Check Benitec Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$304.9M

EPS (TTM)

-0.98

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-8.92

Industry PE ratio

-7.33

PEG Ratio

-0.17

EBITDA

-50.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-28.41%

Benitec Biopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Benitec Biopharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$304.9M-86.33%-8.920.00%0.00%
Neutral$88.5B-36.40%-27.78-12.57%0.00%
StrongBuy$141.7B208.09%32.2786.04%0.00%
Buy$95.5B45.26%19.7685.77%0.40%

Stock Returns calculator for Benitec Biopharma Stock including INR - Dollar returns

The Benitec Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Benitec Biopharma investment value today

Current value as on today

₹55,508

Returns

-₹44,492

(-44.49%)

Returns from Benitec Biopharma Stock

-₹48,105 (-48.11%)

Dollar Impact

₹3,613 (+3.61%)

Analyst Recommendation on Benitec Biopharma Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Benitec Biopharma. Average target price of $23.29

Benitec Biopharma Share Price Target

Get share price movements and forecasts by analysts on Benitec Biopharma.

What analysts predicted

63.55%UPSIDE

Target Price

$23.29

Current Price

$8.49

Analyzed by

4 Analysts

High

$32

Target

$23.29

Low

$14

Benitec Biopharma target price $23.29, a slight upside of 63.55% compared to current price of $8.49. According to 4 analysts rating.

Indian Investors' Interest in Benitec Biopharma Stock

Search interest for Benitec Biopharma Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-33% versus previous 30 day period

Benitec Biopharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
0
-
-
-
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-4
-5
-5
-10
-15
-9
-9
-13
-13
-14
EBITDA
-4
-5
-5
-10
-15
-17
-9
-13
-13
-14
Interest Expense
0
-
0
-
-
-1
-1
-1
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-4
-5
-9
-14
-8
-8
-11
-11
-12
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-4
-4
-5
-9
-14
-16
-8
-11
-11
-12
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
50.00%
0.00%
0.00%
0.00%
0.00%

Benitec Biopharma Annual Profit & Loss

All numbers in Millions USD

Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Total Revenue
4
17
0
0
0
0
-
-
-
Gross Profit
3
15
0
0
0
0
0
0
0
Operating Income
-8
3
-8
-13
-17
-19
-22
-41
-51
EBITDA
-16
2
-7
-13
-17
-18
-22
-41
-50
Interest Expense
-
-
-
0
0
0
-
-3
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
3
-8
-13
-18
-19
-21
-37
-45
Income Tax Expense
-4
-
-
-
-
-
-
-
-
Net Income
-12
3
-8
-13
-18
-19
-21
-37
-45
Net Profit Margin
27.26%
96.23%
290.72%
-108.47%
87.67%
-408.00%
0.00%
0.00%
0.00%

Benitec Biopharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-4
-4
-5
-7
-9
-8
-8
-11
-11
-12
Operating Cash Flow
-6
-3
-4
-7
-3
-8
-3
-3
-4
-4
Investing Cash Flow
0
0
-
0
0
0
-
0
0
0
Financing Cash Flow
0
40
21
17
28
4
-
98
4
0
Change in Cash
-6
36
16
10
25
-5
-3
94
-4
-4

Benitec Biopharma Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Net Income
-4
-8
2
-8
-13
-18
-19
-21
-37
-45
Operating Cash Flow
-8
-8
4
-7
-12
-15
-18
-19
-23
-16
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
7
8
0
1
22
-
16
68
70
98
Change in Cash
0
-1
4
-5
9
-15
-1
48
46
82

Global Institutional Holdings in Benitec Biopharma

Check out the Institutions with significant holdings in Benitec Biopharma.

Funds
Holdings
Peter Kolchinsky
5.30%
Suvretta Capital Management, LLC
5.30%
Franklin Strategic Series
3.88%
Vanguard
3.32%
Simplify
3.11%

Benitec Biopharma News & Key Events

  • img

    Today's Timeline - 28 October

    Wed, 05:58 PM

    -

    Benitec Biopharma reports positive interim results from BB-301 trial, with all nine patients classified as responders and no serious adverse events.

Insights on Benitec Biopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, BNTC stock has moved up by 142.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 211.3% return, outperforming this stock by 69.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 716.3% return, outperforming this stock by 762.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, -8.96M → -12.80M (in $), with an average decrease of 13.4% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 556.0K → -833.04K (in $), with an average decrease of 249.8% per quarter

About Benitec Biopharma

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
OrganisationBenitec Biopharma
Headquarters3940 Trust Way, Hayward, CA, 94545, US
IndustryBiotechnology
CEOJerel A. Banks

Key Management of Benitec Biopharma

Name

Title

Ms. Sophie Mukadam

Chief Operating Officer

Dr. Michael Graham

Head of Discovery & Founding Scientist

Dr. Claudia Kloth Ph.D.

Senior Vice President of Manufacturing

FAQs

What is Benitec Biopharma share price today?

Benitec Biopharma share price today is $8.49 as on at the close of the market. Benitec Biopharma share today touched a day high of $8.81 and a low of $8.24.

What is the 52 week high and 52 week low for Benitec Biopharma share?

Benitec Biopharma share touched a 52 week high of $16.31 on and a 52 week low of $7.89 on . Benitec Biopharma stock price today i.e. is closed at $8.49,which is 47.95% down from its 52 week high and 7.67% up from its 52 week low.

What is Benitec Biopharma's market capitalisation today?

Benitec Biopharma market capitalisation is $0.00T as on .

How to invest in Benitec Biopharma Stock (BNTC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Benitec Biopharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Benitec Biopharma Stock (BNTC) from India?

Indian investors can start investing in Benitec Biopharma (BNTC) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Benitec Biopharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Benitec Biopharma share’s latest price of $8.49 as on November 3, 2026 at 2:29 am IST, you will get 1.1779 shares of Benitec Biopharma. Learn more about fractional shares .

What are the returns that Benitec Biopharma has given to Indian investors in the last 5 years?

Benitec Biopharma stock has given -86.33% share price returns and 27.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?